Role of glial cell derived neurotrophic factor in the protective effect of SMILAGENIN (cas 126-18-1) on rat mesencephalic dopaminergic neurons damaged by MPP+

Add time:09/25/2019    Source:sciencedirect.com

Tyrosine hydroxylase immunohistochemical analysis revealed that in cultured mesencephalic dopaminergic neurons SMILAGENIN (cas 126-18-1) (SMI), added prior to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPP+), protected against the drop of neuron number and neurite outgrowth length caused by MPP+. Addition of anti-GDNF and/or anti-GFRα1 functional antibodies to the medium prior to SMI, eliminated mostly, though incompletely, the action of SMI. The expression of glial cell derived neurotrophic factor (GDNF) mRNA, but not GDNF receptor alpha1 (GFRα1) or receptor tyrosine kinase mRNA in MPP+ intoxicated neurons was markedly elevated as early as 2 h after the addition of SMI with a peak at 24–48 h. Therefore, an important route of the protective action of SMI on dopaminergic neurons is to stimulate intrinsic GDNF expression.

We also recommend Trading Suppliers and Manufacturers of SMILAGENIN (cas 126-18-1). Pls Click Website Link as below: cas 126-18-1 suppliers

Prev:Regulation of M1-receptor mRNA stability by SMILAGENIN (cas 126-18-1) and its significance in improving memory of aged rats
Next:Epi-Sarsasapogenin and epi-SMILAGENIN (cas 126-18-1): two sapogenins isolated from the rumen content of sheep intoxicated by Brachiaria decumbens)